Delivery Order SPE2DB20D3103-SPE2DB25FM4W1

Award Date 1/28/25
Potential Completion Date 1/29/25
Potential Value $2.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,859.80 firm fixed-price delivery order is for the supply of CARVEDILOL ER 20 MG CAPSULE 30S, a cardiovascular medication, to support military healthcare programs. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,797.03, is a Firm Fixed Price Delivery Order for the supply of CARVEDILOL ER 10 MG CAPSULE 30S, a cardiovascular medication. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,312.44 firm fixed-price delivery order is for the supply of CARVEDILOL ER 20 MG CAPSULE 30S, a cardiovascular medication. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,872.12 firm fixed-price delivery order is for the supply of CARVEDILOL ER 20 MG CAPSULE 30S, a cardiovascular medication. This contract is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,521.04 firm-fixed-price delivery order is for the supply of CARVEDILOL ER 80 MG CAPSULE 30S, a cardiovascular medication. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a comprehensive vehicle...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of CARVEDILOL ER 20 MG CAPSULE 30S, a cardiovascular medication, with a ceiling value of $2,415.44 and a completion date of January 14, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,233.05 fixed-price delivery order is for the supply of CARVEDILOL ER 10 MG CAPSULE 30S, a cardiovascular medication, with a performance period through January 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,032.34 Firm Fixed Price Delivery Order contract is for the supply of CARVEDILOL ER 20 MG CAPSULE 30S, a cardiovascular medication. The contract has an ultimate completion date of February 5, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,423.56 Firm Fixed Price Delivery Order contract is for the supply of CARVEDILOL ER 20 MG CAPSULE 30S, a medication used to treat cardiovascular conditions. The contract has an ultimate completion date of January 17, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $1,705.54, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CARVEDILOL ER 20 MG CAPSULE 30S, a cardiovascular medication, to support military healthcare programs. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FM4W1
    Delivery Order

This federal contract award, issued by the Defense Logistics Agency (DLA), was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,299.67 firm fixed-price delivery order is for the supply of CARVEDILOL ER 10 MG CAPSULE 30S, a cardiovascular medication.

The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC, which runs through November 2026, encompasses a wide array of critical medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

The contract award does not have a set-aside designation, indicating open competition. Amerisourcebergen is the prime contractor, and there is no mention of any major subcontractors. This contract supports the DLA's mission of providing medical supplies and pharmaceuticals to the U.S. military and other federal healthcare programs.

Generated 4/29/25, 9:42 AM